Letter by Gazmuri and Karmazyn Regarding Article, "Activation and Inhibition of SodiumHydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure"

被引：1

作者：

Gazmuri, Raul J. ^{[1
,2
,3
]}

Karmazyn, Morris

机构：

[1] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60064 USA

[2] Rosalind Franklin Univ Med & Sci, Dept Clin Sci, N Chicago, IL 60064 USA

[3] Captain James A Lovell Fed Hlth Care Ctr, Sect Crit Care Med, N Chicago, IL 60064 USA

来源：

CIRCULATION | 2018年 / 137卷 / 18期

关键词：

D O I：

10.1161/CIRCULATIONAHA.117.032824

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1979 / 1980

页数：2

共 50 条

[31] Letter by Forfia and Borlaug Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"
Forfia, Paul R.
Borlaug, Barry A.
CIRCULATION, 2012, 125 (08) : E408 - E408
[32] Letter by Xu et al. regarding article, "Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction"
Xu, Xiaoqun
Zhu, Houyong
Xu, Kan
HEART FAILURE REVIEWS, 2023, 28 (02) : 571 - 572
[33] Letter by Komamura Regarding Article, "Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction"
Komamura, Kazuo
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (10) : E273 - E273
[34] Letter by Barrios et al Regarding Article, "Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial"
Barrios, Vivencio
Escobar, Carlos
Echarri, Rocio
CIRCULATION, 2009, 120 (05) : E31 - E31
[35] Letter by Gordon et al Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"
Gordon, Brian
McDiarmid, Adam
MacGowan, Guy
CIRCULATION, 2012, 125 (08) : E406 - E406
[36] Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials"
Lytvyn, Yuliya
Bjornstad, Petter
Udell, Jacob A.
Lovshin, Julie A.
Cherney, David Z. I.
CIRCULATION, 2018, 137 (18) : 1984 - 1985
[37] Letter by Barrios et al Regarding Article, "Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial" Response
Davis, Barry R.
Simpson, Lara M.
Ford, Charles E.
Kostis, John B.
Black, Henry R.
Cushman, William C.
Einhorn, Paula T.
Farber, Michael A.
Levy, Daniel
Massie, Barry M.
Nawaz, Shah
CIRCULATION, 2009, 120 (05) : E32 - E32
[38] Effects of tafamidis on heart failure hospitalization: the tale of the dog that did not bark. Letter regarding the article 'Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms'
Aimo, Alberto
Vergaro, Giuseppe
Emdin, Michele
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 526 - 526
[39] Letter by Wang et al Regarding Article, "Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction"
Wang, Daxin
Mao, Yongqing
Wang, Ti
Xiong, Ting
Yang, Xinquan
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (09) : E260 - E261
[40] Response to the letter regarding the article "Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: The plavix use for treatment of diabetes (PLUTO-Diabetes) trial"
Serebruany, Victor
AMERICAN HEART JOURNAL, 2008, 155 (06)

← 1 2 3 4 5 →